




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Chronic Angina</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=58616d42-1fda-49eb-a3ed-40ba0d5d99c0</link>
        <description>Clinical Topic Feed: Chronic Angina</description>
        <language>en</language>

        

                <item>
                    <title>PIONEER IV: Angiography-Derived FFR vs. Usual Care in Patients Undergoing PCI</title>
<link>/Latest-in-Cardiology/Articles/2026/11/02/22/45/tues-145pm-pioneer-tct-2026</link>                    <description>Noninferiority of angiography-derived fractional flow reserve (angio-FFR) was not met when compared to usual care in patients undergoing PCI, according to results of the PIONEER IV trial, presented at TCT 2026.</description>
                    <pubdate>1793733600000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>TomorrowLAND: Does Intracoronary Nicorandil Prevent No-Reflow in STEMI Patients Undergoing PCI?</title>
<link>/Latest-in-Cardiology/Articles/2026/11/01/00/11/mon-627pm-pci-stemi-tct-2026</link>                    <description>Prolonged perfusion balloon predilation and intracoronary delivery of Nicorandil with the Rx Ryusei perfusion balloon did not significantly reduce slow-flow or no-reflow in patients presenting with STEMI undergoing primary PCI, according to findings from the TomorrowLAND trial presented at TCT 2026.</description>
                    <pubdate>1793662020000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ANDES, PREMIUM Trials Test Different Antithrombotic Strategies After LAAC, Primary PCI</title>
<link>/Latest-in-Cardiology/Articles/2026/10/26/16/55/sat-fcr2-tct-2026</link>                    <description>Two randomized trials published in JACC and presented as Featured Clinical Research at TCT 2026 examine whether scaling back antithrombotic therapy, using short-term anticoagulation rather than dual antiplatelet therapy (DAPT) after left atrial appendage closure (LAAC) and omitting aspirin during primary STEMI in high-risk patients, can limit bleeding while maintaining protection against thrombotic events.</description>
                    <pubdate>1793559180000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC Journals Highlight Challenging Cases From TCT 2026</title>
<link>/Latest-in-Cardiology/Articles/2026/10/26/16/55/sat-challenging-cases-tct-2026</link>                    <description>New challenging cases presented at TCT 2026 and simultaneously published across the JACC family of journals offer insights into key questions and challenging scenarios in interventional cardiology.</description>
                    <pubdate>1793558940000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC: Advances Studies Highlight Mobile STEMI Care, AI-Driven CT Imaging</title>
<link>/Latest-in-Cardiology/Articles/2026/10/26/16/55/sat-ai-combo-tct-2026</link>                    <description>A mobile app for optimizing STEMI care and use of AI to detect aortic valve calcification on routine noncontrast chest CT are among the innovations being discussed and presented at TCT 2026 and simultaneously published in JACC: Advances.</description>
                    <pubdate>1793474880000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Firefighters &amp; Cardiac Death; HFimpEF &amp; Sex Differences; DAPT, DOAC, and LAAO; Non-lnfarct-Related IRA &amp; CAD</title>
<link>/Latest-in-Cardiology/Articles/2026/10/28/13/38/eagles-eye-view-28oct2026</link>                    <description>n this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at a brief report on how cardiac death remains a substantial contributor to on-duty mortality of U.S. firefighters, and how drivers of this trend may not be well identified by the current screening approaches.</description>
                    <pubdate>1793194860000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Acute Coronary Occlusions Associated With Worse In-Hospital Outcomes Among Patients With NSTEMI | NCDR Study</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/10/20/19/27/Acute-Coronary-Occlusions</link>                    <description>A significant proportion of patients with NSTEMI had acute coronary occlusions (ACOs), and ACO was associated with worse in-hospital outcomes among patients in the NSTEMI cohort, according to a recent study published in JACC: Cardiovascular Interventions.</description>
                    <pubdate>1792587600000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Noninfarct-Related Artery PCI in Patients With STEMI and Multivessel CAD | NCDR Study</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/10/20/19/27/Noninfarct-Related-Artery-PCI</link>                    <description>Noninfarct-related artery (non-IRA) revascularization in patients with STEMI and multivessel coronary artery disease (CAD) increased modestly from 2018 to 2022; however, a majority of patients did not undergo non-IRA PCI within 45 days of primary PCI, according to a recent study published in Circulation: Cardiovascular Interventions.</description>
                    <pubdate>1792587600000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Interventional Post-ACS Antithrombotic Trials at ESC Congress 2026</title>
<link>/Latest-in-Cardiology/Articles/2026/10/16/17/49/Trials-at-ESC</link>                    <description>Four late-breaking trials, presented at ESC Congress 2026 focused on post-acute coronary syndrome (ACS) antithrombotic therapy.</description>
                    <pubdate>1792177140000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Emerging Evidence: Refractory Angina and Coronary Sinus Reducers</title>
<link>/Latest-in-Cardiology/Articles/2026/10/14/12/36/Emerging-Evidence</link>                    <description>Refractory angina (RA) is an increasing global cardiovascular challenge, affecting approximately 10-15% of patients with coronary artery disease (CAD). RA is defined as persistent anginal symptoms (&#226;‰&#165;3 months) due to myocardial ischemia despite guideline-directed medical therapy...</description>
                    <pubdate>1791999300000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>